Found 0 matching trials
Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes PHASE1 Single-center, double-blind, random-sequence study assessing the HDV dose-r...
Show More Location
Multiple Locations
Learn More & Join Trial
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas PHASE2 Subjects will participate in three weeks of the bionic pancreas in the insu...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes PHASE2 Postprandial meal glucose control with closed-loop systems (CLS) still need...
Show More Location
Institut de recherches cliniques de Montréal
Learn More & Join Trial
Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients PHASE3 The study is designed to approve non-inferior efficacy and safety of Insuli...
Show More Location
Chelyabinsk Railway Clinical Hospital
Learn More & Join Trial
BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance PHASE1 The study is designed to compare meal time glucose control associated with ...
Show More Location
Profil Institute for Clinical Research, Inc. (PICR)
Learn More & Join Trial
Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20 PHASE1 The purpose of the study is to compare the pharmacokinetics (PK) and pharma...
Show More Location
Diabetes and Glandular Disease Research, Inc.
Learn More & Join Trial
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus PHASE1 The main purpose of this study is to learn more about a new formulation of ...
Show More Location
Profil Institut für Stoffwechselforschung
Learn More & Join Trial
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose PHASE1 The purpose of this study is to measure the effect of LY2189265 to increase...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study) PHASE3 Type 2 diabetes mellitus is a chronic metabolic disorder characterized by p...
Show More Location
Mount Sinai Hospital
Learn More & Join Trial
Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) PHASE3 Type 2 diabetes mellitus is a chronic metabolic disorder characterized by p...
Show More Location
Mount Sinai Hospital
Learn More & Join Trial